Defensive medicine and the influence of litigation on doctors
Authors:
Z. Adamová 1; H. Adamová 2
Authors place of work:
Ústav práva a humanitních věd Provozně ekonomické fakulty Mendelovy univerzity v Brně
; Chirurgické oddělení, Vsetínská nemocnice, a. s.
; Chirurgické oddělení, Nemocnice ve Frýdku-Místku
1; Nejvyšší soud ČR
2
Published in the journal:
Rozhl. Chir., 2022, roč. 101, č. 6, s. 260-264.
Category:
Souhrnné sdělení
doi:
https://doi.org/10.33699/PIS.2022.101.6.260–264
Summary
The term defensive medicine is used to describe the behavior of healthcare providers motivated by fear of litigation due to malpractice. It includes both avoidance behavior when the physician is unwilling to perform high risk procedures, as well as excessive ordering of extra tests and procedures. This leads to unnecessary diagnostic and therapeutic interventions which may be invasive and costly. Additionally, such a setting causes harms the patient-doctor relationship. A more specific legal framework, developed with respect to the innate nature of medicine, may improve the situation.
Keywords:
legislation – defensive medicine – economics in medicine
Zdroje
1. Dove JT, Brush JE Jr, Chazal RA, et al. Medical professional liability and health care system reform. J Am Coll Cardiol. 2010;55(25):2801–2803. doi:10.1016/j. jacc.2010.03.028.
2. Studdert DM, Mello MM, Sage WM, et al. Defensive medicine among high-risk specialist physicians in a volatile malpractice environment. JAMA 2005;293(21):2609– 2617.
3. Sethi MK, Obremskey WT, Natividad H, et al. Incidence and costs of defensive medicine among orthopedic surgeons in the United States: a national survey study. Am J Orthop (Belle Mead NJ) 2012;41(2):69–73. PMID: 22482090.
4. Nahed BV, Babu MA, Smith TR, et al. Malpractice liability and defensive medicine: a national survey of neurosurgeons. PLoS One. 2012;7(6):e39237. doi:10.1371/journal. pone.0039237.
5. Cheng YW, Snowden JM, Handler SJ, et al. Litigation in obstetrics: does defensive medicine contribute to increases in cesarean delivery? J Matern Fetal Neonatal Med. 2014 Nov;27(16):1668–1675. doi:10. 3109/14767058.2013.879115.
6. Rudey EL, Leal MDC, Rego G. Defensive medicine and cesarean sections in Brazil. Medicine (Baltimore). 2021;100(1):e24176. doi:10.1097/ MD.0000000000024176.
7. Brateanu A, Schramm S, Hu B, et al. Quantifying the defensive medicine contribution to primary care costs. J Med Econ. 2014;17(11):810–816. doi:10.3111/13696 998.2014.959125.
8. Yan SC, Hulsbergen AFC, Muskens IS, et al. Defensive medicine among neurosurgeons in the Netherlands: a national survey. Acta Neurochir. 2017;159(12):2341– 2350. doi:10.1007/s00701-017-3323-9.
9. Frati P, Busardo FP, Sirignano P, et al. Does defensive medicine change the behaviors of vasclular surgeons? A qualitative review. Biomed Res Int. 2015;2015:170692. doi:10.1155/2015/170692.
10. Panella M, Rinaldi C, Leigheb F, et al. Prevalence and costs of defensive medicine: a national survey of Italian physicians. J Health Serv Res Policy. 2017;22(4):211–217. doi:10.1177/ 1355819617707224.
11. Vento S, Cainelli F, Vallone A. Defensive medicine: It is time to finally slow down an epidemic. World J Clin Cases. 2018;6(11):406–409. doi:10.12998/wjcc. v6.i11.406.
12. Osti M, Steyrer J. A national survey of defensive medicine among orthopaedic surgeons, trauma surgeons and radiologists in Austria: evaluation of prevalence and context. J Eval Clin Pract. 2015 Apr;21(2):278–284. doi:10.1111/ jep.12305.
13. Santoro E. Clinical-judicial syndrome: how a doctor becomes a patient through general indifference. Updates Surg. 2014;66:173–175. doi:10.1007/s13304- 014-0264-1.
14. Panella M, Rinaldi C, Leigheb F, et al. The determinants of defensive medicine in Italian hospitals: The impact of being a second victim. Rev Calid Asist. 2016;31 Suppl 2:20–5. doi:10.1016/j. cali.2016.04.010.
15. DVTV https://video.aktualne.cz/dvtv/ jsem-spatny-z-toho-jak-ted-lide-pristupuji- k-vede-internet-j/r~e98bf4de- 495c11ec878fac1f6b220ee8/ z 20. 11. 2021.
Štítky
Chirurgie všeobecná Ortopedie Urgentní medicínaČlánek vyšel v časopise
Rozhledy v chirurgii
2022 Číslo 6
- Metamizol jako analgetikum první volby: kdy, pro koho, jak a proč?
- Cinitaprid – v Česku nová účinná látka nejen pro léčbu dysmotilitní dyspepsie
- Neodolpasse je bezpečný přípravek v krátkodobé léčbě bolesti
Nejčtenější v tomto čísle
- Retroperitoneální fibróza – diagnostika a léčba
- Atraumatický akutní kompartment syndrom − kazuistika
- Defenzivní medicína a vliv hrozby soudních sporů na lékaře
- Opožděně diagnostikovaná ruptura bránice po tupém traumatu hrudníku – 2 kazuistiky